[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB202301312D0 - Method and product - Google Patents

Method and product

Info

Publication number
GB202301312D0
GB202301312D0 GBGB2301312.1A GB202301312A GB202301312D0 GB 202301312 D0 GB202301312 D0 GB 202301312D0 GB 202301312 A GB202301312 A GB 202301312A GB 202301312 D0 GB202301312 D0 GB 202301312D0
Authority
GB
United Kingdom
Prior art keywords
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2301312.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PCI Biotech AS
Original Assignee
PCI Biotech AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PCI Biotech AS filed Critical PCI Biotech AS
Priority to GBGB2301312.1A priority Critical patent/GB202301312D0/en
Publication of GB202301312D0 publication Critical patent/GB202301312D0/en
Priority to PCT/EP2024/052243 priority patent/WO2024160824A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2301312.1A 2023-01-30 2023-01-30 Method and product Ceased GB202301312D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2301312.1A GB202301312D0 (en) 2023-01-30 2023-01-30 Method and product
PCT/EP2024/052243 WO2024160824A1 (en) 2023-01-30 2024-01-30 Photochemical internalization of mycobacterium bovis bacille calmette-guérin for use in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2301312.1A GB202301312D0 (en) 2023-01-30 2023-01-30 Method and product

Publications (1)

Publication Number Publication Date
GB202301312D0 true GB202301312D0 (en) 2023-03-15

Family

ID=85476583

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2301312.1A Ceased GB202301312D0 (en) 2023-01-30 2023-01-30 Method and product

Country Status (2)

Country Link
GB (1) GB202301312D0 (en)
WO (1) WO2024160824A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (en) 1994-09-08 1997-02-26 Photocure As Photochemical method for introducing molecules into the cytosol of cells
GB9905911D0 (en) 1999-03-15 1999-05-05 Photocure As Method
GB201208548D0 (en) 2012-05-15 2012-06-27 Pci Biotech As Compound and method
WO2015154832A1 (en) 2014-04-11 2015-10-15 Pci Biotech As Method of treating melanoma
CA3040344A1 (en) 2016-10-14 2018-04-19 Pci Biotech As Treatment of cholangiocarcinoma with tpcs-2a induced photochemical internalisation of gemcitabine
GB202115451D0 (en) * 2021-10-27 2021-12-08 Pci Biotech As Method

Also Published As

Publication number Publication date
WO2024160824A1 (en) 2024-08-08

Similar Documents

Publication Publication Date Title
EP4030680A4 (en) Application processing method and related product
GB202013709D0 (en) Aquafaba products and methods
GB201902992D0 (en) Product and method
GB202307460D0 (en) Method and product
GB202301312D0 (en) Method and product
GB202216552D0 (en) Method and Product
GB202211433D0 (en) Method and product
EP4289282A4 (en) Pseudo-meat food product and method for producing pseudo-meat food product
PL4094915T3 (en) Pouch-forming apparatus and forming method
GB2597998B (en) Product and method
GB2597999B (en) Product and method
GB202000517D0 (en) Method, product and apparatus
GB202101443D0 (en) Method and products
GB202012320D0 (en) Method and products
EP3979743A4 (en) Sidelink implementation method and related product
GB202413796D0 (en) Product and process
GB202216018D0 (en) Process and product
GB2614585B (en) Wingsail and method
GB202300532D0 (en) Article and method
GB202111734D0 (en) Hyperpolarisation method and product
EP4251118A4 (en) Skin-cleansing product and method for obtaining said product
GB2595465B (en) Insulation product and method for making insulation product
GB202100819D0 (en) Process and Product Thereof
GB202005605D0 (en) Methods and products
GB202004902D0 (en) Methods and products

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)